Armenian Hamster IgG Isotype Control – Purified In vivo GOLD™ Functional Grade

Pricing & Details

  
Clone
PIP
Formats AvailableView All
Product Type
Isotype Control
Isotype
Armenian Hamster
IgG
Prod No.
Size
Price
Avail.
Qty
Add to cart
I-140-1.0 mg
1.0 mg
$95.00
In stock
I-140-5.0 mg
5.0 mg
$298.00
In stock
I-140-25 mg
25 mg
$775.00
In stock
I-140-50 mg
50 mg
$1,275.00
In stock
I-140-100 mg
100 mg
$1,998.00
In stock
  
Host Species
Armenian Hamster
Product Concentration
0.5 mg/ml
Formulation
This monoclonal antibody is aseptically packaged and formulated in 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Product Preparation
Functional grade preclinical antibodies are manufactured in an animal free facility using only In vitro cell culture techniques and are purified by a multi-step process including the use of protein A or G to assure extremely low levels of endotoxins, leachable protein A or aggregates.
Storage and Handling
Functional grade preclinical antibodies may be stored sterile as received at 2-8°C for up to one month. For longer term storage, aseptically aliquot in working volumes without diluting and store at -80°C. Avoid Repeated Freeze Thaw Cycles.
Working Concentration
This isotype control antibody should be used at the same concentration as the primary antibody.
Applications and Recommended Usage ?
(Quality Tested by Leinco)
ELISA Sandwich: This antibody is useful as the capture antibody in a sandwich ELISA. The suggested coating concentration is 5 µg/ml (100 µl/well) µg/ml.

Flow Cytometry: PN:M114

Western Blotting: To detect Human CASP8 by Western blot analysis, this antibody can be used at a concentration of 1.0-2.0 µg/ml (1:100 Dilution). When used in conjunction with compatible second step reagents such as PN:M114 and a chromogenic substrate such as PN:T343, the detection limit for Human CASP8 is 1.0 ng/lane under either reducing or non-reducing conditions.
Specificity
This Armenian Hamster IgG isotype control monoclonal antibody has been tested against selected species' cells and tissues to assure minimal cross-reactivity.

References & Citations

1. Schreiber, RD. et al. (2017) Cancer Immunol Res. 5(2):106-117. PubMed
2. Oldstone, MBA. et al. (2017) Proc Natl Acad Sci U S A. 114(14): 3708–3713. PubMed
3. Schreiber, RD. et al. (2015) PLoS One.10(5):e0128636. PubMed
3. Diamond, MS. et al. (2017) J Virol. 91(22): e01419-17. PubMed
  

Formats Available

Products are for research use only. Not for use in diagnostic or therapeutic procedures.